These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 12888934)
1. Role of coagulation and fibrinolytic system in prostate cancer. Kohli M; Kaushal V; Mehta P Semin Thromb Hemost; 2003 Jun; 29(3):301-8. PubMed ID: 12888934 [TBL] [Abstract][Full Text] [Related]
2. Clinical studies with anticoagulants to improve survival in cancer patients. Gerotziafas GT; Papageorgiou C; Hatmi M; Samama MM; Elalamy I Pathophysiol Haemost Thromb; 2008; 36(3-4):204-11. PubMed ID: 19176993 [TBL] [Abstract][Full Text] [Related]
3. Overview of the postulated mechanisms linking cancer and thrombosis. ten Cate H; Falanga A Pathophysiol Haemost Thromb; 2008; 36(3-4):122-30. PubMed ID: 19176985 [TBL] [Abstract][Full Text] [Related]
4. The fibrinolytic system in experimental prostate tumor. Al-Mondhiry H; Drago J; Bartholomew MJ Thromb Haemost; 1986 Oct; 56(2):133-6. PubMed ID: 3810552 [TBL] [Abstract][Full Text] [Related]
5. Clotting mechanisms and cancer: implications in thrombus formation and tumor progression. Falanga A; Marchetti M; Vignoli A; Balducci D Clin Adv Hematol Oncol; 2003 Nov; 1(11):673-8. PubMed ID: 16258469 [TBL] [Abstract][Full Text] [Related]
6. Thrombophilia in cancer. Falanga A Semin Thromb Hemost; 2005 Feb; 31(1):104-10. PubMed ID: 15706482 [TBL] [Abstract][Full Text] [Related]
7. The association between blood coagulation markers, atherothrombosis and dementia. Gupta A; Pansari K Int J Clin Pract; 2003 Mar; 57(2):107-11. PubMed ID: 12661793 [TBL] [Abstract][Full Text] [Related]
8. Disseminated intravascular coagulation with excessive fibrinolysis in prostate cancer: a case series and review of the literature. Hyman DM; Soff GA; Kampel LJ Oncology; 2011; 81(2):119-25. PubMed ID: 21986538 [TBL] [Abstract][Full Text] [Related]
9. Clinical application of fibrinolysis laboratory tests: a review. Prisco D; Conti AA; Giurlani L; Falciani M Ann Ital Med Int; 1998; 13(2):81-7. PubMed ID: 9734140 [TBL] [Abstract][Full Text] [Related]
10. Angiogenesis of prostate cancer and antiangiogenic therapy. Uehara H J Med Invest; 2003 Aug; 50(3-4):146-53. PubMed ID: 13678383 [TBL] [Abstract][Full Text] [Related]
11. The role of the stromal microenvironment in prostate cancer. Condon MS Semin Cancer Biol; 2005 Apr; 15(2):132-7. PubMed ID: 15652458 [TBL] [Abstract][Full Text] [Related]
12. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers. Langer F; Chun FK; Amirkhosravi A; Friedrich M; Leuenroth S; Eifrig B; Bokemeyer C; Francis JL Thromb Haemost; 2007 Mar; 97(3):464-70. PubMed ID: 17334515 [TBL] [Abstract][Full Text] [Related]
13. Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Belting M; Ahamed J; Ruf W Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1545-50. PubMed ID: 15905465 [TBL] [Abstract][Full Text] [Related]
14. Low-molecular-weight heparin in thrombosis and cancer. Mousa SA Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():25-30. PubMed ID: 15085463 [TBL] [Abstract][Full Text] [Related]
15. [Pathogenesis of venous thromboembolic disease in cancer]. Elalamy I; Verdy E; Gerotziafas G; Hatmi M Pathol Biol (Paris); 2008 Jun; 56(4):184-94. PubMed ID: 18485617 [TBL] [Abstract][Full Text] [Related]
16. [Prostate cancer and disseminated intravascular coagulation: review of the literature]. Chargari C; Vedrine L; Bauduceau O; Le Moulec S; Fayolle M; Ceccaldi B; Houlgatte A Prog Urol; 2008 Jan; 18(1):9-13. PubMed ID: 18342149 [TBL] [Abstract][Full Text] [Related]
17. The role of the plasminogen activation system in cancer. Carroll VA; Binder BR Semin Thromb Hemost; 1999; 25(2):183-97. PubMed ID: 10357086 [TBL] [Abstract][Full Text] [Related]